✦ LIBER ✦

The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial

✍ Scribed by Victor Novack; Miruna Eisinger; Amit Frenkel; Marius Terblanche; Neill K. J. Adhikari; Amos Douvdevani; Doron Amichay; Yaniv Almog

Publisher: Springer
Year: 2009
Tongue: English
Weight: 194 KB
Volume: 35
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-009-1429-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gabapentin in patients with the pruritus

Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial

✍ Nora V. Bergasa; Monnie McGee; Iona H. Ginsburg; Danielle Engler 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

✍ J.W.A.S. Sander; P.N. Patsalos; J.R. Oxley; M.J. Hamilton; W.C. Yuen 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 616 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled trial of the effects of fluoride on lumbar spine bone density in patients with rhematoid arthritis

✍ J. D. Adachi; M. J. Bell; W. G. Bensen; F. A. Bianchi; A. Cividino; E. Kaminska; 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 109 KB

Placebo and nocebo effects in randomized

Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer

✍ Maxine de la Cruz; David Hui; Henrique A. Parsons; Eduardo Bruera 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract ## BACKGROUND: A significant response to placebo in randomized controlled trials of treatments for cancer‐related fatigue (CRF) had been reported. A retrospective study was conducted to determine the frequency and predictors of response to placebo effect and nocebo effects in patients

Mirtazapine add-on therapy in the treatm

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti